Prospective, Randomized Controlled Pivotal Trial of Biodegradable Balloon Rectal Spacer for Prostate Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics · 2024
DOI: 10.1016/j.ijrobp.2024.07.2145 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024. Verfasst von Daniel Song und 15 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland. Electronic address: kerma99@gmail.com. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Rectum. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
PURPOSE/OBJECTIVES: Rectal spacers have been shown to reduce rectal side effects in patients receiving prostate radiation. However, concerns remain regarding precise and reproducible gel injection. We evaluated efficacy and safety of a novel rectoprostatic spacer balloon that allows potential for controlled, adaptable deployment. This study tested co-primary hypotheses: (1) balloon spacer would result in ≥25% reduction of rectal V70 in >75% of subjects and (2) implantation procedure-related and rectal ≥grade 1 adverse events within 6 months (duration ≥2 days, Common Terminology Criteria for Adverse Events 4.0) would be noninferior in balloon versus control subjects. METHODS AND MATERIALS: A total of 222 subjects were enrolled at 16 centers. All patients had T1-T3 prostate cancer without magnetic resonance imaging evidence of posterior extraprostatic invasion. Randomization was 2:1 (balloon: control) and subject-blinded. Patients underwent transperineal transrectal ultrasound axial and sagittal-guided fiducial placement ± balloon, followed by Intensity-Modulated Radiation Therapy (81 Gy in 1.8 Gy fractions or biologically equivalent hypofractionated dose). For efficacy comparisons, plans were generated by a central core lab on pre- and postimplant computed tomography scans. RESULTS: The primary efficacy endpoint was met, with 97.9% of balloon subjects (139/142) having rectal V70 reduction >25% (P < .001). Mean V70 was 7.0 % pre- versus 1.1% postimplant. The primary safety endpoint was met with balloon subjects experiencing fewer ≥grade 1 events, 18% versus 23% (P < .001 for noninferiority). On predefined secondary endpoint of ≥grade 2 events, rates trended lower in balloon subjects (4.3% vs 6.5%, P = .527). Mean perirectal spacing was 19 ± 3.7 mm and maintained through radiation treatment (18 ± 3.9 mm). Balloon resorption was observed on 6-month computed tomography in 98.5% (133/135) of subjects. The Expanded Prostate Cancer Index quality of life instrument was collected throughout study, and did not differ statistically between the study arms. CONCLUSIONS: Biodegradable rectal spacer balloon was effective in significantly reducing dose to rectum, and associated with decreased cumulative rectal plus implantation-related adverse events. Balloon resorption was consistently observed by 6 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland. Electronic address: kerma99@gmail.com.
- Department of Brachytherapy, Oncology Center Institute of Maria Skłodowska Curie (MCMCC), Warsaw, Poland.
- CUF Porto Instituto Rua Fonte das Sete Bicas, Senhora da Hora Matosinhos, Portugal.
- Western Radiation Oncology (WRO), B Campbell, California.
- Northern Nevada Radiation Oncology, Reno, Nevada.
- MAASTRO Clinic Dr. Tanslaan, Maastricht, The Netherlands.
Zitieren
APA
Song, D., Dabkowski, M., Costa, P., Nurani, R., Kos, M., Vanneste, B., Magel, D., Sapir, E., Zimberg, S., Boychak, O., Soffen, E., Alhasso, A., Tokita, K., Wang, D., Symon, Z., & Hudes, R. (2024). Prospective, Randomized Controlled Pivotal Trial of Biodegradable Balloon Rectal Spacer for Prostate Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2024.07.2145
Vancouver
Song D, Dabkowski M, Costa P, Nurani R, Kos M, Vanneste B, et al. Prospective, Randomized Controlled Pivotal Trial of Biodegradable Balloon Rectal Spacer for Prostate Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 2024. doi:10.1016/j.ijrobp.2024.07.2145
BibTeX
@article{Song2024,
author = {Song, Daniel and Dabkowski, Mateusz and Costa, Paulo and Nurani, Rizwan and Kos, Michael and Vanneste, Ben and Magel, David and Sapir, Eli and Zimberg, Shawn and Boychak, Oleksandr and Soffen, Edward and Alhasso, Abdulla and Tokita, Kenneth and Wang, Dian and Symon, Zvi and Hudes, Richard},
title = {Prospective, Randomized Controlled Pivotal Trial of Biodegradable Balloon Rectal Spacer for Prostate Radiation Therapy},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
doi = {10.1016/j.ijrobp.2024.07.2145}
}
EUVIMED